Skip to article frontmatterSkip to article content
Site not loading correctly?

This may be due to an incorrect BASE_URL configuration. See the MyST Documentation for reference.

Overview

The ClpXP control module enables the ATP-dependent, targeted degradation of ssrA-tagged proteins McGinness, Baker, and Sauer, 2006. It is based on the complex formed by the AAA+ ATPase ClpX and the tetradecameric peptidase ClpP. The module can be implemented using purified protein, in situ expressed proteins from DNA templates, or combinations thereof.

Schematic
Designs
Cartoon of the general mechanism of protein degradation by ClpXP, an ATP-dependent protease. Adapted from  R. Wedam, et al.

Cartoon of the general mechanism of protein degradation by ClpXP, an ATP-dependent protease. Adapted from R. Wedam, et al.

Cytosols

Usage

The module can be implemented from purified proteins alone, from in situ expressed proteins encoded on DNA templates, or from combinations thereof.

Purified Proteins
In Situ Expression

Reaction Table 1. The control module implemented from purified proteins. Volumes in µL.

ComponentSample 1Sample 2Sample 3Control
Purified deGFP-ssrA (41.2 µM)0.50.50.50.5
Purified ClpP (79.9 µM)0.50.500
Purified ClpX (53.7 µM)0.500.50
NEB PURExpress Solution A4444
NEB PURExpress Solution B3333
RNase Inhibitor0.50.50.50.5
Nucleus Free Water11.51.52
Total10101010

Expected Performance

Module performance in PURE is documented in the DevNote ClpXP Module Validation in PURE.

Purified Proteins
In Situ Expression
GFP fluorescence of samples containing purified proteins incubated at 37°C for 4 hours. These results correspond to Reaction Table 1.

GFP fluorescence of samples containing purified proteins incubated at 37°C for 4 hours. These results correspond to Reaction Table 1.

Cells

Cell-context validation of the ClpXP module is documented in the DevNote ClpXP Module Validation in Cells.

The ClpXP Control Module in the context of the Developer Cell. Other Developer Cell Modules are grayed out.

The ClpXP Control Module in the context of the Developer Cell. Other Developer Cell Modules are grayed out.

References
  1. McGinness, K. E., Baker, T. A., & Sauer, R. T. (2006). Engineering Controllable Protein Degradation. Molecular Cell, 22(5), 701–707. 10.1016/j.molcel.2006.04.027
  2. Wedam, R., Greer, Y. E., Wisniewski, D. J., Weltz, S., Kundu, M., Voeller, D., & Lipkowitz, S. (2023). Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. Cancers, 15(7), 1936. 10.3390/cancers15071936